Rabbit Recombinant Monoclonal TAU phospho S199 antibody. Suitable for Dot, WB and reacts with Synthetic peptide, Mouse, Human samples. Cited in 13 publications.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
IHC-P | Dot | WB | |
---|---|---|---|
Human | Not recommended | Expected | Tested |
Mouse | Not recommended | Expected | Tested |
Rat | Not recommended | Predicted | Predicted |
Synthetic peptide | Not recommended | Tested | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human, Rat, Mouse, Synthetic peptide | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Human | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 1/5000 - 1/20000 | Notes - |
Species Human | Dilution info 1/5000 - 1/20000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide | Dilution info - | Notes - |
Select an associated product type
The protein expressed by the MAPT gene promotes microtubule assembly and stability and might be involved in establishing and maintaining neuronal polarity. Its C-terminus binds axonal microtubules, and the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between the two. Axonal polarity is predetermined by MAPT localization within the neuronal cell's domain defined by the centrosome. The short isoforms allow cytoskeleton plasticity, whereas the longer isoforms may preferentially play a role in its stabilization. This supplementary information is collated from multiple sources and compiled automatically.
TAU_HUMAN, MAPT phospho S199
MAPTL, MTBT1, TAU, MAPT, Microtubule-associated protein tau, Neurofibrillary tangle protein, Paired helical filament-tau, PHF-tau
Rabbit Recombinant Monoclonal TAU phospho S199 antibody. Suitable for Dot, WB and reacts with Synthetic peptide, Mouse, Human samples. Cited in 13 publications.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
The specificity of this antibody refers to P10636-8.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Tau also known as microtubule-associated protein Tau (MAPT) plays an important role in stabilizing microtubules in neuronal cells. Tau is primarily found in the central nervous system but also exists in peripheral neurons. Human Tau protein comes in six isoforms due to alternative splicing with molecular weights ranging from 48 kDa to 67 kDa. This protein predominantly locates in the axons of neurons where it maintains the stability of microtubule tracks necessary for axonal transport.
Tau is involved in the assembly and stabilization of microtubules essential for maintaining neuronal structure. It interacts with microtubule-binding domains (MBD) to bind and bundle microtubules facilitating intracellular transport. Tau forms a part of the neuronal cytoskeleton complex working closely with other cytoskeletal proteins to preserve the proper axonal transport and function. Abnormally phosphorylated Tau often termed phospho-Tau disrupts this complex affecting microtubule stability.
Tau has critical involvement in several signaling cascades such as the microtubule-binding and transport pathways. Glycogen synthase kinase 3 beta (GSK3β) and cyclin-dependent kinase 5 (CDK5) frequently phosphorylate Tau controlling its interaction with microtubules. Phosphorylated Tau accumulates leading to the formation of neurofibrillary tangles often observed in neurodegenerative conditions. Additionally Tau interacts with GAPDH impacting cellular energy regulation through potential pathway cross-talk involving oxidative stress responses.
Tau is closely associated with Alzheimer's disease and frontotemporal dementia. In Alzheimer's disease hyperphosphorylated Tau aggregates into paired helical filaments forming neurofibrillary tangles while similar aggregates are observed in frontotemporal dementia. In these conditions Tau links to amyloid precursor protein (APP) where misregulated phosphorylation-driven interactions contribute to neurodegeneration. Identifying phospho-Tau and its altered interactions with related proteins aids in understanding and potentially treating these disorders.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Dot blot analysis using 1/1000 dilution ab81268 and Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (Goat Anti-Rabbit IgG H&L (HRP) ab97051) secondary at 1/100000 dilution.
Blocking and diluting buffer: 5% NFDM/TBST
Lane 1: Tau non-phospho peptide
Lane 2: Tau S199 phospho peptide
Lane 3: Tau S202 phospho peptide
Lane 4: Tau S199+S202 phospho peptide
Exposure time: 3 minutes
All lanes: Western blot - Anti-Tau (phospho S199) antibody [EPR2401Y] (ab81268) at 1/1000 dilution
Lane 1: Mouse cerebral cortex tissue lysate at 10 µg
Lane 2: Mouse cerebral cortex tissue lysate, The membrane was incubated with phosphatase at 10 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Predicted band size: 78 kDa
Observed band size: 55 kDa
Exposure time: 5s
All lanes: Western blot - Anti-Tau (phospho S199) antibody [EPR2401Y] (ab81268) at 1/1000 dilution
Lane 1: Human hippocampus tissue lysate at 10 µg
Lane 2: Human hippocampus tissue lysate. The membrane was incubated with phosphatase. at 10 µg
All lanes: Western blot - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/2000 dilution
Predicted band size: 78 kDa
Observed band size: 55 kDa
Exposure time: 1min
Dot blot analysis of Tau (pS199) peptide (Lane 1) and Tau non-phospho peptide (Lane 2) labelling Tau (pS199) with ab81268 at a dilution of 1/1000. Goat Anti-Rabbit IgG H&L (HRP) ab97051 (peroxidase-conjugated goat anti-rabbit IgG (H+L)) was used as the secondary antibody at a dilution of 1/100000.
Exposure time: 3 minutes.
Blocking and dilution buffer: 5% NFDM/TBST.
All lanes: Western blot - Anti-Tau (phospho S199) antibody [EPR2401Y] (ab81268) at 1/20000 dilution
Lane 1: SH SY5Y cell lysate at 10 µg
Lane 2: SH SY5Y cell lysate treated with alkaline phosphatase at 10 µg
All lanes: HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 78 kDa
Observed band size: 55 kDa
Tau (phospho S199) Western blot staining using rabbit Anti-Tau (phospho S199) antibody
Blocking and dilution buffer: 5% NFDM/TBST.
All lanes: Western blot - Anti-Tau (phospho S199) antibody [EPR2401Y] (ab81268) at 1/1000 dilution
Lane 1: 293T cells transfected with an empty vector containing a flag tag whole cell lysate at 20 µg
Lane 2: 293T cells transfected with a human Tau expression vector containing a flag whole cell lysate at 20 µg
Lane 3: 293T cells transfected with a human MAP2 expression vector containing a flag whole cell lysate at 20 µg
Lane 4: 293T cells transfected with a human MAP4 expression vector containing a flag whole cell lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 78 kDa
Observed band size: 55-100 kDa
Exposure time: 1s
Image collected and cropped by CiteAb under a CC-BY license from the publication
Tau (phospho S199) western blot using anti-Tau (phospho S199) antibody [EPR2401Y] ab81268. Publication image and figure legend from Yang, S. H., Lee, D. K., et al., 2017, EMBO Mol Med, PubMed 27861127.
ab81268 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab81268 please see the product overview.
Nec‐1 inhibits the phosphorylation and aggregation of tauAWestern blot analysis of phosphorylation levels of tau and expression levels of indicated proteins in the cortical and hippocampal regions of the brain in APP/PS1 mice after administration of Nec‐1 (6.25 mg/kg) or vehicle (2.5% DMSO in PBS). The membranes analysed are identical to those in Fig 5F.BImmunohistochemical analysis of cortical and hippocampal regions of the brains in wild‐type (Wt) and APP/PS1 mice after administration of Nec‐1 (6.25 mg/kg) or vehicle (2.5% DMSO in PBS) for phosphorylated tau expression levels. Anti‐tau (phospho‐Ser199) antibody (red colour) was applied for staining tau phosphorylation on serine‐199 and Hoechst 33342 (blue colour) for nuclear counterstaining in the brain sections. Scale bars = 200 μm. Yellow and red boxes indicate the cortical and hippocampal region of brains, respectively.CWestern blot analyses of phosphorylated RIPK3 expression in cortex and hippocampus of APP/PS1 mice injected with Nec‐1 (upper), and primary cultured astrocytes treated with Nec‐1 (lower). The membranes analysed are identical to those in Figs 1G and 5F.D, EThT assays for the inhibition of tau aggregation (D) and for disaggregation of tau (E). Fluorescence intensity was normalized to tau aggregates (100%, day 5). All data are representative results of at least three independent experiments.FSurface plasmon resonance sensorgrams of Nec‐1 targeting tau (left), and the corresponding dissociation fitting curve from the saturated region (right) under various concentrations of Nec‐1.Data information: In (D and E), data are presented as mean ± SEM. ***P ≤ 0.001 (one‐way ANOVA followed by Bonferroni's post hoc comparisons tests). Exact P‐values are shown in Table EV5. Source data are available online for this figure.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com